Oorsprong van het eerstegraads netwerk van Alexander Scheer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
7
| Extinct | Pharmaceuticals: Major | 7 |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Merck Serono SAS
 Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Alexander Scheer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IMUNON, INC. | Biotechnology | Chief Executive Officer | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| VILMORIN & CIE | Agricultural Commodities/Milling | Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| SANOFI | Biotechnology | Corporate Officer/Principal | |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
| KIORA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | President | |
| MICHELIN (CGDE) | Automotive Aftermarket | Corporate Officer/Principal | |
| MORPHOSYS AG | Biotechnology | Chief Executive Officer | |
| CFAO | Wholesale Distributors | Director/Board Member | |
| University of Rhode Island | College/University | Undergraduate Degree | |
| SCYNEXIS, INC. | Pharmaceuticals: Major | General Counsel | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | General Counsel | |
| The College of William & Mary | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Masters Business Admin | |
| École Normale Supérieure | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Masters Business Admin | |
Pacific Council on International Policy
 Pacific Council on International Policy Miscellaneous Commercial ServicesCommercial Services Pacific Council on International Policy operates as a foreign affairs firm. The firm specializes International Affairs, International Relations, Foreign Policy, Foreign Affairs, Public Policy, National Security, International Economics, Government, Professional Networking, Events, Non Profit, International Policy and International Business, Analysis. The company was founded in 1995 and is headquartered in Los Angeles, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Leem | Director/Board Member | ||
| QUANTUM GENOMICS | Pharmaceuticals: Major | Director/Board Member | |
Pierre Fabre Dermo-Cosmétique SAS
 Pierre Fabre Dermo-Cosmétique SAS Household/Personal CareConsumer Non-Durables Pierre Fabre Dermo-Cosmétique SAS manufactures cosmetics and pharmaceutical products. The company was founded on March 20, 1991 and is headquartered in Boulogne-Billancourt, France. | Household/Personal Care | Chairman | |
Sanofi Pasteur MSD SNC
 Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
| Kenan-Flagler Business School | College/University | Masters Business Admin | |
| Sorbonne Université | College/University | Masters Business Admin | |
Pierre Fabre Ltd.
 Pierre Fabre Ltd. Household/Personal CareConsumer Non-Durables Part of Pierre Fabre Participations SAS, Pierre Fabre Ltd. is a British company that develops innovative solutions for the well-being of everyone, from health to beauty. The company is based in London, UK. The company's flagship products include purifying mist, fortifying shampoo, dry shampoo, and anti-dandruff shampoo for hair care, as well as treatments for chronic diseases such as heavy legs, urinary disorders, allergies, type 2 diabetes, and anemia. The company also offers a range of iconic brands under the Pierre Fabre brand, including Eau Thermale Avène, Ducray, Dexeryl, Eludril, Elgydium, and Naturactive. The company has a best practices guide for relations with patient associations to ensure responsible and sound decision-making. | Household/Personal Care | Director/Board Member | |
PIQUR Therapeutics AG
 PIQUR Therapeutics AG Pharmaceuticals: OtherHealth Technology PIQUR Therapeutics AG engages in development of anti-cancer drugs based on the inhibition. Its products include PQR309, PQR620 and PQR5xx. The company was founded by Bernd Giese, Vladimir Cmiljanovic, Andreas Emmenegger, Ralf Rosenow and Matthias Wymann in August 2011 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Other | Chief Executive Officer | |
| Roche SAS | President | ||
| Imaginons La Santé | President | ||
Aelix Therapeutics SL
 Aelix Therapeutics SL BiotechnologyHealth Technology Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain. | Biotechnology | Chief Executive Officer | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
| POLAREAN IMAGING PLC | Medical Specialties | Corporate Officer/Principal | |
Innoven Partners
 Innoven Partners Financial ConglomeratesFinance Innoven Partners is an investment fund. The private company is based in Paris, France. | Financial Conglomerates | Corporate Officer/Principal | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
| Faculté De Médecine Necker Enfants Malades Université | College/University | Doctorate Degree | |
| VIATRIS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pierre Fabre Group
 Pierre Fabre Group Household/Personal CareConsumer Non-Durables Pierre Fabre Group manufactures cosmetics and skincare products. The private company is based in Paris, France. The CEO of the French company is Eric Ducournau. | Household/Personal Care | Chief Executive Officer | |
| BCLS ACQUISITION CORP. | Financial Conglomerates | Director/Board Member | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| EUROAPI | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 22 |
| Frankrijk | 21 |
| Duitsland | 4 |
| Zwitserland | 3 |
| Verenigd Koninkrijk | 3 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 13 |
| Consumer Non-Durables | 4 |
| Finance | 3 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 27 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 15 |
| Chief Executive Officer | 14 |
| General Counsel | 7 |
Sterkste connecties
- Beurs
- Insiders
- Alexander Scheer
- Bedrijfsconnecties